#Medical Device Outsourcing Market share

[neha24blog]

Medical Device Analytical Testing Outsourcing Market Segmented On The Basis Of Services, Device Type, End-Use, Therapeutic Areas, Region And Forecast 2030: Grand View Research Inc.

Medical Device Analytical Testing Outsourcing Market Segmented On The Basis Of Services, Device Type, End-Use, Therapeutic Areas, Region And Forecast 2030: Grand View Research Inc.

San Francisco, 9 Dec 2022: The Report Medical Device Analytical Testing Outsourcing Market Size, Share & Trends Analysis Report By Services, By Therapeutic Areas ,By Device Type ,By End-use, By Region And Segment Forecasts, 2022 – 2030 The global medical device analytical testing outsourcing market size is expected to reach USD 10.6 billion by 2030, registering a CAGR of 8.1% over the forecast…

[industrynewsupdates]

Clinical Trials Procurement Intelligence 2024-2030: What You Need to Know

This clinical trials market is anticipated to grow at a CAGR of 6.49% from 2024 to 2030. North America is the leading region in this category, accounting for over 50.3% of the market share in 2023. This is expected to continue in the forecast period as well, due to several factors, including increased R&D investments and the adoption of new technologies. For example, the use of virtual services in clinical trials is becoming increasingly popular, and this is expected to drive growth in the North American market.

This category is driven by many key factors, including the surge in demand for outsourcing clinical trials, the increasing prevalence of chronic diseases, and the increased investments in R&D by pharmaceutical and biotechnological companies. The outsourcing of this category is becoming increasingly popular, as it allows pharmaceutical companies to focus on their core competencies and to save time and money. The increasing prevalence of chronic diseases is also driving the demand for clinical trials, as there is a need for the development of new and efficient therapeutics to treat these diseases. Also, the increased investments in R&D by pharmaceutical and biotechnological companies are driving the growth of the market, as these companies are constantly developing new drugs and therapies that need to be tested in clinical trials.

This category is a moderately fragmented market due to the presence of numerous players. Strategic alliances between pharmaceutical firms and CROs are anticipated to have a substantial impact on the category’s expansion. Additionally, the swift uptake of new technology for better healthcare contributes to the market's expansion. For instance,

• In November 2022, Calit Health Services (Israel) and IQVIA (US) announced a collaboration to work on clinical trial delivery. The collaboration will combine Calit's extensive clinical trial experience and IQVIA's global reach and expertise in data analytics.

• In April 2022, Charles River Laboratories, a pharmaceutical company that provides preclinical and clinical laboratory services, acquired Explora BioLabs, a provider of contract vivarium research services. This acquisition will allow Charles River to expand its offerings in the cell and gene therapy space.

• In February 2022, Citeline and Norstella merged to form a new company worth $5 billion. Citeline provides clinical trial management software, while Norstella provides clinical trial supplies and services. The merger of these two companies will allow them to offer a more comprehensive suite of services to pharmaceutical companies, which could help speed up the drug development process and improve patient access to new therapies.

Order your copy of the Clinical Trials Procurement Intelligence Report, 2024 - 2030, published by Grand View Research, to get more details regarding day one, quick wins, portfolio analysis, key negotiation strategies of key suppliers, and low-cost/best-cost sourcing analysis

Technological advancements in this category have revolutionized the drug development process by reducing costs and increasing efficiency. With rising trial expenses, failure rates, and a focus on patient-centric trials, the demand for the technology in clinical trials has surged. The landscape of clinical trials is evolving towards decentralization with the utilization of wearables, mHealth, and real-world evidence (RWE). These disruptive technologies enable small, controlled trials and streamline processes from patient enrollment to medication administration and follow-ups through mobile devices. Pharmaceutical companies are investing heavily in AI and big data analytics to leverage their transformative impact on the R&D process, enhance competitiveness, and facilitate company transformation and agility. Additionally, the integration of wearable devices and remote sample collection offers a safer and more convenient experience for participants, potentially increasing patient enrollment and engagement in future studies.

Defining the price and cost of this category is complex as it is dependent on various factors like phase, drug type, and location. Costs range from millions to billions, divided into patient care and research costs. Patient care costs include recruitment, enrollment, medication, safety monitoring, while research costs cover design, implementation, data analysis, and results publication. When budgeting for a clinical trial, consider various cost segments like regulatory, safety, data, quality management, overhead, and site costs. The price of this category is determined by the trial sponsor, typically a pharmaceutical company. Various factors can influence the trial's price, including its scale, complexity, and associated risks. Sponsors take these factors into account when setting the price, as they impact the resources required to conduct a successful trial.

When it comes to sourcing of this category, it is crucial to follow the best practices to ensure the high quality and integrity of the study. These practices include identifying reputable trial sites, evaluating investigator qualifications, prioritizing patient safety, assessing site capabilities, reviewing ethical considerations, evaluating data management systems, monitoring compliance with regulations, conducting site visits and audits. Additionally, it is essential to prioritize suppliers who offer comprehensive documentation, including certificates of analysis and trials conducted. By following these best practices, sponsors can enhance the quality, reliability, and ethical standards of their clinical trials. Finally, considering suppliers who engage in continuous research and development efforts can be beneficial for this category.

Clinical Trials Procurement Intelligence Report scope

• Clinical Trials Category Growth Rate: CAGR of 6.49% from 2024 to 2030

• Pricing Growth Outlook: 2% - 3% (Annually)

• Pricing Models: Unit-based pricing

• Supplier Selection Scope: Cost and pricing, Past engagements, Productivity, Geographical presence

• Supplier selection criteria: Reviewing ethical considerations, prioritizing patient safety, regulatory standards and mandates, category innovations, and others

• Report Coverage: Revenue forecast, supplier ranking, supplier matrix, emerging technology, pricing models, cost structure, competitive landscape, growth factors, trends, engagement, and operating model

Browse through Grand View Research’s collection of procurement intelligence studies:

• Clinical IT Services Procurement Intelligence Report, 2023 - 2030 (Revenue Forecast, Supplier Ranking & Matrix, Emerging Technologies, Pricing Models, Cost Structure, Engagement & Operating Model, Competitive Landscape)

• Clinical Staffing Services Procurement Intelligence Report, 2023 - 2030 (Revenue Forecast, Supplier Ranking & Matrix, Emerging Technologies, Pricing Models, Cost Structure, Engagement & Operating Model, Competitive Landscape)

Key companies profiled

• IQVIA

• PAREXEL International Corporation

• Pharmaceutical Product Development

• Charles River Laboratory

• ICON Plc

• Syneos Health

• Chiltern International Ltd

• Eli Lilly and Company

• Pfizer

• Caidya

Brief about Pipeline by Grand View Research:

A smart and effective supply chain is essential for growth in any organization. Pipeline division at Grand View Research provides detailed insights on every aspect of supply chain, which helps in efficient procurement decisions.

Our services include (not limited to):

• Market Intelligence involving – market size and forecast, growth factors, and driving trends

• Price and Cost Intelligence – pricing models adopted for the category, total cost of ownerships

• Supplier Intelligence – rich insight on supplier landscape, and identifies suppliers who are dominating, emerging, lounging, and specializing

• Sourcing / Procurement Intelligence – best practices followed in the industry, identifying standard KPIs and SLAs, peer analysis, negotiation strategies to be utilized with the suppliers, and best suited countries for sourcing to minimize supply chain disruptions

[industryforecastnews]

Healthcare Contract Development And Manufacturing Organization Market To Reach USD 471.0 Billion By 2030

Healthcare Contract Development and Manufacturing Organization Market Growth & Trends

The global healthcare contract development and manufacturing organization market size is expected to reach USD 471.0 billion by 2030, growing at a CAGR of 9.68% from 2024 to 2030, according to a new report by Grand View Research, Inc. The market is expected to show lucrative growth due to rising outsourcing trends and increasing R&D expenditure.

Healthcare contract development and manufacturing organization (CDMO) provide outsourcing services to various pharmaceutical industries on a contract basis. An increase in outsourcing by pharmaceutical companies, expansions in the pharmaceutical industry, and the support of CDMOs in reducing operational and capital expenses are some of the major factors anticipated to propel the market growth in the forecast period.

In addition, growing requirement among pharmaceutical and medical device companies to follow stringent timelines has increased the demand for outsourcing development and manufacturing activities to CDMOs. Further, due to the increasing demand for medical devices in emerging countries, various companies are shifting their focus on research and development activities for medical device contract development and manufacturing. Over the past 10 years, several pharmaceutical companies have turned to CMOs, CROs, and CDMOs to assist in pre-formulation and development & manufacturing of their novel innovations. Outsourcing is a high growth market, and most spending is focused on early development.

Around 75% of new drug pipelines come from small- and midsized biopharmaceutical companies. These companies have high profit margins, which make them easy targets for healthcare providers who are trying to reduce costs. Thus, instead of investing in establishing their own infrastructure, it is profitable for these companies to outsource services to third-party organizations that have expertise and the required equipment. Several pharmaceutical companies are seeking outsourced services for optimizing the development of their molecules. Furthermore, a large number of CDMO collaborations, expansions, mergers & acquisitions, and other strategic initiatives undertaken by market players operating in the country are anticipated to boost the market. For instance, In March 2023, Remedium Bio, a U.S.-based biotechnology company, entered into a collaboration agreement with Exothera, a Belgium-based CDMO, to scale up the production of Remedium’s lead gene therapy drug candidate, AAV2-FGF18 in the treatment of osteoarthritis. Similarly, in January 2024, Enzene Biosciences, a subsidiary of Alkem Labs announced the manufacturing site in the U.S. Such innovations are anticipated to drive the market.

However, increasing logistic costs, serialization issues faced by healthcare organizations, and the threat of infringement of Intellectual Property (IP) rights are anticipated to restrain the market growth for healthcare contract development & manufacturing organization over the forecast period.

Request a free sample copy or view report summary: https://www.grandviewresearch.com/industry-analysis/healthcare-contract-development-manufacturing-organization-market

Healthcare Contract Development and Manufacturing Organization Market Report Highlights

Based on services, the contract manufacturing segment dominated the market with a revenue share of 73.50% in 2023 due to increase in the outsourcing of manufacturing services by pharmaceutical and medical device companies.In addition, cost-effectiveness, and the increasing number of CMOs are some of the key factors that are positively affecting the market growth

By small molecule contract development sub-segment, the preclinical/segment is expected to register the highest CAGR of 9.53% in the forecast period due to the rising pipeline of novel therapeutics

North America dominated the healthcare contract development and manufacturing organization industry with the largest revenue share of 40.91%in 2023. High shares of the region are majorly due to the presence of a large number of actively functioning CROs and CMOs in the region, especially across the U.S.

Healthcare Contract Development and Manufacturing Organization Market Segmentation

For this study, Grand View Research has segmented the healthcare contract development and manufacturing organization market based on services and region:

Healthcare CDMO Services Outlook (Revenue, USD Billion, 2018 - 2030)

Contract Development

Small Molecule

Preclinical

Bioanalysis and DMPK Studies

Toxicology Testing

Other Preclinical Services

Clinical

Phase I

Phase II

Phase III

Phase IV

Laboratory Services

Bioanalytical Services

Analytical Services

Large Molecule

Cell Line development

Process Development

Upstream

Microbial

Mammalian

Others

Downstream

MABs

Recombinant Proteins

Others

Others

Contract Manufacturing

Small Molecule

Large Molecule

MABs

Recombinant Proteins

Others

High Potency API

Finished Dose Formulations

Solid Dose Formulation

Liquid Dose Formulation

Injectable Dose Formulation

Medical Devices

Class I

Class II

Class III

Healthcare CDMO Regional Outlook (Revenue, USD Billion, 2018 - 2030)

North America

U.S.                

Canada

Europe

Germany

UK

France

Italy

Spain

Netherlands

Belgium

Denmark

Norway

Sweden

Asia Pacific

China

India

Japan

Australia

South Korea

Malaysia

New Zealand

Singapore

Philippines

Thailand

Latin America

Brazil

Mexico

Argentina

Colombia

Chile

Middle East & Africa

South Africa

Saudi Arabia

UAE

Israel

Kuwait

List of Key Players in the Healthcare CDMO Market

Catalent Inc.

Lonza

Recipharm AB

Siegfried Holding AG

Thermo Fisher Scientific, Inc.

Labcorp Drug Development

Jabil Inc

Syngene International Limited

IQVIA Inc.

Almac Group

Ajinomoto Bio-Pharma

Adare Pharma Solutions

Alcami Corporation

Vetter Pharma International

Browse Full Report: https://www.grandviewresearch.com/industry-analysis/healthcare-contract-development-manufacturing-organization-market

[tamanna31]

Small Molecule Innovator CDMO Market - The Biggest Trends to watch out for 2024-2030

Small Molecule Innovator CDMO Industry Overview

The global small molecule innovator CDMO market size was estimated at USD 48.6 billion in 2023 and is expected to expand at a compound annual growth rate (CAGR) of 6.21% from 2024 to 2030. Key drivers for this growth are increasing pharmaceutical R&D investment, growing demand for small molecules, and rising incidence of cancer & age-related disorders. Biological drugs are more expensive than small molecules. Hence, growing demand for cost-effective drugs is expected to further support market growth.

The COVID-19 pandemic significantly impacted on global economy in 2020 and caused an ongoing impact on various industries. However, the market for contract development and manufacturing organization (CDMO) witnessed a positive impact due to this pandemic. CDMOs played an important role in meeting the needs of pharmaceutical companies, biotech companies, and other end-users during this crisis. Overall, pandemic boosted market demand for small molecule innovator drugs. With the growing demand for outsourcing by pharma companies, heightened demand is observed in post-pandemic scenario.

Gather more insights about the market drivers, restrains and growth of the Small Molecule Innovator CDMO Market

Small Molecule Innovator CDMO Market Segmentation

Grand View Research has segmented the global small molecule innovator CDMO market based on product, stage type, customer type, therapeutic area, and region:

Small Molecule Innovator CDMO Product Outlook (Revenue, USD Million, 2018 - 2030)

Small Molecule API

Small Molecule Drug Product

Oral solid dose

Semi-Solid Dose

Liquid Dose

Others

Small Molecule Innovator CDMO Stage Type Outlook (Revenue, USD Million, 2018 - 2030)

Preclinical

Clinical

Phase I

Small

Medium

Large

Phase II

Small

Medium

Large

Phase III

Small

Medium

Large

Commercial

Small Molecule Innovator CDMO Customer Type Outlook (Revenue, USD Million, 2018 - 2030)

Pharmaceutical

Small

Medium

Large

Biotechnology

Small Molecule Innovator CDMO Therapeutic Area Outlook (Revenue, USD Million, 2018 - 2030)

Cardiovascular disease

Oncology

Respiratory disorders

Neurology

Metabolic disorders

Infectious disease

Others

Browse through Grand View Research's Medical Devices Industry Research Reports.

The global intrauterine devices marketsize was estimated at USD 6.25 billion in 2023 and is projected to grow at a CAGR of 3.66% from 2024 to 2030.

The global dual chamber prefilled syringes marketsize was valued at USD 167.3 million in 2023 and is projected to grow at a CAGR of 5.8% from 2024 to 2030.

Key Companies & Market Share Insights

Companies are undertaking various strategic initiatives to gain a competitive advantage. Key parameters affecting the competitive nature of the market include acquisition, geographic expansion, mergers, acquisitions, and product launches.

In September 2022, WuXi STA inaugurated a new sterile lipid nanoparticle (LNP) formulation development and manufacturing facility at its Wuxi city campus. The integrated drug product platform CRDMO provides a full range of services, including solid-state development, pre-formulation, and clinical to commercial drug product manufacturing.

In June 2022, Lonza inaugurated a new clinical phase development and manufacturing facility in its small molecules site in Bend, Oregon. It is dedicated to manufacturing bioavailability-enhancing spray-dried dispersion (SDD) finished dosage forms and drug product intermediates

List of Key Players of Small Molecule Innovator CDMO Market

Piramal Pharma Solutions

CordenPharma International

Wuxi AppTec

Cambrex Corporation

Recipharm AB

Pantheon (Thermo Fisher Scientific)

Lonza

Catalent Inc.

Siegfried Holding AG

Boehringer Ingelheim

Labcorp Drug Development

Order a free sample PDF of the Small Molecule Innovator CDMO Market Intelligence Study, published by Grand View Research.

[trendingreportz]

South East Asia Testing, Inspection & Certification Market - Forecast (2024-2030)

South East Asia Testing, Inspection & Certification (TIC) Market Overview

The South East Asia TIC Market size is estimated to reach US$4.7 billion by 2030, growing at CAGR 4.82% during the forecast period 2024-2030. The growth of South East Asia TIC Market is majorly driven by increasing need for food testing and rising safety regulations and standards for the enhancement of medical device safety measure. Moreover, the rapid growth of consumer electronics industry coupled with the increasing demand for electronics will also trigger the growth of the testing, inspection & certification market in South East Asia. The manufacturer of electronic products needs to comply with various governmental standards to ensure quality testing and certification through RoHS testing, Electromagnetic compatibility (EMC) testing, GS mark certification, CPSR and so on, which in turn drives the market growth of TIC (Testing, Inspection & Certification) services. Furthermore, the demand for TIC services which includes failure & damage analysis, various component testing, e-mobility & battery testing and others in automotive industry is also a major factor that can transform the South East Asia TIC industry outlook in the long run. 

The South East Asia Testing, Inspection, and Certification (TIC) market is undergoing significant transformation driven by multiple converging trends. The region's rapid industrialization and economic growth are increasing the demand for robust TIC services to ensure compliance with international standards and regulations. Advancements in digital technologies, such as blockchain, IoT, and AI, are revolutionizing TIC processes, enhancing the accuracy and efficiency of inspections and certifications. The growing emphasis on quality and safety in sectors like food and beverages, pharmaceuticals, and consumer goods is fueling the need for stringent testing and certification protocols. Additionally, the expansion of the manufacturing sector, particularly in automotive and electronics, is driving the demand for specialized TIC services to maintain quality control and meet export requirements. The rise of e-commerce is also contributing to the market growth, as online retailers seek to ensure product safety and authenticity. Environmental sustainability and regulatory compliance are becoming increasingly important, prompting companies to adopt comprehensive TIC services to meet green standards and reduce environmental impact. These trends collectively are enhancing the significance of TIC services in ensuring product quality, safety, and compliance across various industries in South East Asia.

South East Asia TIC Report Coverage

The “South East Asia TIC Market Report – Forecast (2024-2030)” by IndustryARC, covers an in-depth analysis of the following segments in the South East Asia TIC Market.

By Type: Outsourcing, In-house

By Types of Services: Testing Services, Inspection Services, Certification Services

By End Users: Agriculture, Automotive, Food, Consumers (textile, cosmetic, toys, apparel, furniture, stationary, hand tools), Medical & Life Science, Marine, Manufacturing, Building & Infrastructure, Industrial Equipment, Retail, Rail, E-Commerce, Meteorology, Others. 

By Geography: Indonesia, Malaysia, Sinagpore, Philliphines, Thailand, Vietnam, Others (Myanmar, Laos, Cambodia, Brunei, Timor-Leste)

Request Sample

Key Takeaways

Testing Services held the major market share in 2023 owing to rising implementations of integrated testing solutions for wide range of end users including automation and control systems, battery storage, F&B processing, communication protocol and so on. 

E-Commerce segment is analysed to grow at the fastest rate during the forecast period 2024-2030 owing to increasing internet and mobile phone usage, high penetration of IoT as well as improved e-payment methods& logistics. 

Indonesia held the highest market share in 2023 Vietnam is analysed to grow at the fastest rate during the forecast period 2024-2030 owing to rapid growth of manufacturing sector and rising investments on railway infrastructure.

The increasing demand towards food testing and rising safety regulations and standards imposed by global as well as regional government bodies for the enhancement of medical device safety measure are analysed to significantly drive the market growth of South East Asia TIC market during the forecast period 2023-2030.

South East Asia TIC Market Segment Analysis- by Type of Services

Testing Services held the major market share in 2023 with a market size of $1.7 Billion and is estimated to reach $2.3 Billion by 2030 with a CAGR of around 4.51% during the forecast period 2024-2030. The growth is mainly attributed to rising implementations of integrated testing solutions for wide range of end users including automation and control systems, battery storage, F&B processing, communication protocol, maritime equipment material, oil & gas structure and components and others to increase productivity and customer satisfaction. In September 2022, Intertek announced the launch of their new Vegan Foods Certification. The Intertek Vegan Certification is designed to determine the suitability of food products for vegan and plant-based consumers. These factors are set to influence the growth of global South East Asia industry in the long run.

Inquiry Before Buying

South East Asia TIC Market Segment Analysis- by End User

E-Commerce segment is analysed to grow at the fastest rate of 9.84% during the forecast period 2024-2030. The growth of the E-Commerce in South East Asia is mainly driven by increasing internet and mobile phone usage, high penetration of IoT as well as improved e-payment methods& logistics. According to an article by Inside Monkey, E-commerce growth in Southeast Asia stands out at an 20.6% expansion in 2022, with sales reaching $89.67 billion from $74.36 billion in 2021 and is expected to pass $100 billion by 2023. Ecommerce sites or mobile applications need to undergo different tests including functionality, usability, security, performance, database and mobile application. TIC services judge the authenticity of the websites by testing the design, specifications, functionalities and various features to check their sanity and to ensure the protection level of the sites against any potential threats. Such benefits of these services drive the growth of TIC services market in this region. Moreover, the E-commerce sector in this region witnessing increasing cases of fraud and cyber-attacks which enhances the demand for testing, inspection and certification services in this industry. In Southeast Asia, digital payment methods are becoming increasingly accepted by most businesses and services today. According to a recent Kaspersky research titled “Mapping a secure path for the future of digital payments in APAC” published in April 2022, e-payment are the top encountered threat for most Southeast Asia countries including Indonesia (40%), Malaysia (45%), The Philippines (42%), Singapore (32%), and Vietnam (38%). Thus, significant rise in number of e-payment frauds can cater to the demand for testing, inspection & certification services within the industry.

South East Asia TIC Market Segment Analysis- by Geography

Indonesia held the highest market share of 20.9% in 2023. The economy of Indonesia is majorly driven by exporting of crude oil and natural gas and holds well established manufacturing industry, agriculture, mining and others. According to U.S Energy Information Administration, the production of petroleum and other liquids totalled 887,000 barrels per day in Indonesia in 2022, making it the seventh-largest exporter of liquefied natural gas, thus creating significant opportunities for the growth of the TIC Market. The rising number of railway infrastructure projects can be considered vital in fueling the market demand for quality testing, electromagnetic testing, and related inspection services for rail components used in the construction process within the country. In January 2022, the Indonesian Government announced the construction of the multibillion-dollar railway project with an estimated cost of $7.9 billion. It will involve the deployment of signaling systems, rolling stocks, and many related components. Such projects are bound to drive the need for railway operators or authorities to meet up with the required regulatory compliance, which in turn, can be considered vital in transforming the South East Asia TIC industry outlook in the long run.

Schedule a Call

South East Asia TIC Market Drivers

Rising Demand Towards Food Testing or Inspection due to Increasing Import/Export activities, Agricultural or Food Contamination, Food Safety Violation and Others is Surging the Demand for Testing, Inspection & Certification Services:

The increasing demand towards food testing owing to rising import/export activities, agricultural or food contamination, food safety violation and others is one of the major growth drivers boosting the adoption rate of testing, inspection & certification services in South East Asia. Food industry is considered as a highly regulated industry due to stringent regulatory compliance ensuring food quality assurance and safety for the consumers. The levels of product recalls owing to the presence of harmful ingredients or contamination or the undeclared presence of an allergen or not an approved additives are rising within the Southeast Asian nations. Moreover, the levels of agricultural trade (both export and import) are successively increasing owing to the population boost in various countries under scope, which will support the growth of the TIC market. As per World Bank 2021, the population of Philippines grew by 1.3% in the period of 2019-20. According to International Trade Administration July 2022 update, agricultural imports in Indonesia reached over $24 billion in 2021, owing to high demand for rice, wheat, soybeans, fresh fruits, dairy beef and various feed ingredients. The following marks an increase by $5 billion or 26% from 2020 import values. Furthermore, nearly 57.8% of the total import value regarding the agricultural products in the Indonesia market was dominated by five suppliers including China, Australia, U.S, Brazil as well as India. Such increase in imports can boost the adoption of food testing services which in turn can influence the market growth.

The Safety Regulations and Standards imposed by Global as well as regional government bodies for the enhancement of medical device safety measure is accelerating the growth of South East Asia TIC Market:

A major driver in the South East Asia TIC market is the implementation of stringent regulatory requirements across various industries. Governments in the region are increasingly adopting and enforcing rigorous standards to protect consumer safety, ensure product quality, and safeguard the environment. This regulatory landscape compels companies to adhere to strict testing, inspection, and certification protocols to gain market access and maintain competitiveness. The pharmaceutical and food industries, in particular, face heightened scrutiny, necessitating comprehensive TIC services to comply with health and safety standards. The automotive and electronics sectors also require extensive TIC processes to meet international export standards. The continuous update and tightening of regulations drive the demand for specialized and advanced TIC services, fostering market growth as companies strive to align with evolving compliance requirements.

The rising safety regulations and standards imposed by global as well as regional government bodies for the enhancement of medical device safety measure is creating demand for the TIC services which in turn triggers the growth of this market. The demand for Class III medical devices such as High-frequency ventilators, blood sampling monitors, oxygen supply units and so on have been growing overtime majorly amidst the pandemic as these devices are used to maintain or protect human life. Since these devices require licensed FDA approvals before distribution across countries, the market growth of TIC services is impacted significantly. Medical device testing is critical to the entire medical device development lifecycle to ensure the safety of patients and device users. In January 2021 the Philippines Food and Drug Administration (FDA) issued circular n° 2021-001 on the product standards to which Medical Devices must comply for notification or registration. The circular was issued so that local Manufacturers, Importers and/or Distributors must comply to obtain a certificate of Medical Device notification (CMDN) or a certificate of Medical Device registration (CMDR). In August 2021, FDA had released a list of Class-A 1242 product categories in its circular 2021-017, in order to support and clarify regulatory requirements for medical manufacturers looking for market access within Philippines. Under this, medical device manufacturers of Class A products specified under the ASEAN MDD, need to mandatorily obtain a Certificate of Medical Device Notification, (CMDN), before manufacturing, distribution, importing, selling, or advertising the medical devices within the country. Thus, rise in regulations and standards can boost the demand of testing, inspection & certification services among the medical device manufacturers.

South East Asia TIC Market Challenges 

Lower Level of Digital Adoption by the Key Players coupled with the Continued Impact of Bottlenecks in Trade Flows across South East Asia region owing to Shortage of Cargo Container are Limiting the Market Growth:

Low level of digital adoption coupled with continued impact of bottlenecks in trade flows acts as a major challenge restraining the market growth of TIC market in South East Asia. According to Rothchild & Co report published in May 2021, the testing-inspection-certification digital maturity substantially lags behind the other various end-user industries which shall pose problems in the long-run. Some of the common industries against which the TIC lacked under digital technology is energy, financial institutions, industrial goods, insurance, and telecommunications. Additionally, Shortage of shipping cargos, shipment cancellations, growing freight rates along with many others have emerged as some of the prime factors adversely impacting domestic manufacturing operations across various Southeast Asian countries owing to dependency on raw material imports within the country. According to Westports Holdings Berhad report, Malaysia faces a container throughput slipping 1% year on year to 10.4 million TEUs (20ft equivalent units) in 2021. Container throughput at Westports was down 10% y-o-y in 1Q2022, reaching 2.39 million TEUs versus 2.66 million TEUs handled in 1Q2021 which leads to supply chain disruption. These factors are limiting the demand for South East Asia TIC which in turn hampers the market growth.

Buy Now

South East Asia TIC Industry Outlook

Product launches, acquisitions and R&D activities are key strategies adopted by players in the South East Asia TIC Market. The top 10 companies in the South East Asia TIC market are:

SGS SA

Bureau Veritas

Intertek

DNV GL

TUV SUD AG

ALS GLOBAL

DEKRA SE

Eurofins

Cast Laboratories PTE LTD

Singapore Laboratory Services PTE LTD

Recent Developments

In December 2022- Intertek, a leading Total Quality Assurance provider to industries, announced the launch of Intertek Green R&D, an innovative integrated solution that ensures the sustainability, quality and safety attributes of a product are maintained.

In June 2022- DNV launched the MyISRS digital self-assessment tool. The service is estimated to aid organizations to run an online independent high-level survey for quality assessing applications. Some of the key industries in South East Asia that can benefit from the service include oil and gas, chemicals, utilities, power generation, telecommunication, pharmaceutics, transport, food, and beverage, and maritime. 

[deshpandeisha]

The Future of Medical Device Outsourcing: Trends and Innovations

The global medical device outsourced manufacturing market size was USD 33.38 Billion in 2022 and is expected to register a revenue CAGR of 13.6% during the forecast period, according to the latest analysis by Emergen Research. Rising prevalence of chronic diseases such as diabetes and cardiovascular disease, rapid technological advancements in the product development of medical devices, and increased funding and investments toward early-stage medical technology-based startup companies are some of the key factors driving revenue growth of the medical device outsourced manufacturing market.

Get Download Pdf Sample Copy of this Report@ https://www.emergenresearch.com/request-sample/1760

Competitive Terrain:

The global Medical Device Outsourced Manufacturing industry is highly consolidated owing to the presence of renowned companies operating across several international and local segments of the market. These players dominate the industry in terms of their strong geographical reach and a large number of production facilities. The companies are intensely competitive against one another and excel in their individual technological capabilities, as well as product development, innovation, and product pricing strategies.

The leading market contenders listed in the report are:

Eakin Surgical., IQVIA., SGS SOCIÉTÉ GÉNÉRALE DE SURVEILLANCE SA., Eurofins Scientific, Bio-Rad Laboratories, Inc., Intertek Group plc, Charles River Laboratories, WuXi AppTec, Nipro Corporation, and Johari Digital

Key market aspects studied in the report:

Market Scope: The report explains the scope of various commercial possibilities in the global Medical Device Outsourced Manufacturing market over the upcoming years. The estimated revenue build-up over the forecast years has been included in the report. The report analyzes the key market segments and sub-segments and provides deep insights into the market to assist readers with the formulation of lucrative strategies for business expansion.

Competitive Outlook: The leading companies operating in the Medical Device Outsourced Manufacturing market have been enumerated in this report. This section of the report lays emphasis on the geographical reach and production facilities of these companies. To get ahead of their rivals, the leading players are focusing more on offering products at competitive prices, according to our analysts.

Report Objective: The primary objective of this report is to provide the manufacturers, distributors, suppliers, and buyers engaged in this sector with access to a deeper and improved understanding of the global Medical Device Outsourced Manufacturing market.

Emergen Research is Offering Limited Time Discount (Grab a Copy at Discounted Price Now)@ https://www.emergenresearch.com/request-discount/1760

Market Segmentations of the Medical Device Outsourced Manufacturing Market

This market is segmented based on Types, Applications, and Regions. The growth of each segment provides accurate forecasts related to production and sales by Types and Applications, in terms of volume and value for the period between 2022 and 2030. This analysis can help readers looking to expand their business by targeting emerging and niche markets. Market share data is given on both global and regional levels. Regions covered in the report are North America, Europe, Asia Pacific, Latin America, and Middle East & Africa. Research analysts assess the market positions of the leading competitors and provide competitive analysis for each company. For this study, this report segments the global Medical Device Outsourced Manufacturing market on the basis of product, application, and region:

Segments Covered in this report are:

Device Type Outlook (Revenue, USD Billion; 2019-2032)

IVD Devices

Drug Delivery Devices

Diabetes Care Devices

Cardiovascular Devices

Diagnostic Imaging Devices

Surgical Devices

Others

Service Type Outlook (Revenue, USD Billion; 2019-2032)

Prototyping Development services

Pilot Production services

Device manufacturing services

Injection molding

CNC Machining and Laser Cutting & 3D Printing

Cleaning and Finishing

Others

Quality Management Services

Packaging Validation services

Inspection and Testing Services

Sterilization services

Others

Class of Medical Device Outlook (Revenue, USD Billion; 2019-2032)

Class I

Class II

Class III

Browse Full Report Description + Research Methodology + Table of Content + Infographics@ https://www.emergenresearch.com/industry-report/medical-device-outsourced-manufacturing-market

Major Geographies Analyzed in the Report:

North America (U.S., Canada)

Europe (U.K., Italy, Germany, France, Rest of EU)

Asia Pacific (India, Japan, China, South Korea, Australia, Rest of APAC)

Latin America (Chile, Brazil, Argentina, Rest of Latin America)

Middle East & Africa (Saudi Arabia, U.A.E., South Africa, Rest of MEA)

ToC of the report:

Chapter 1: Market overview and scope

Chapter 2: Market outlook

Chapter 3: Impact analysis of COVID-19 pandemic

Chapter 4: Competitive Landscape

Chapter 5: Drivers, Constraints, Opportunities, Limitations

Chapter 6: Key manufacturers of the industry

Chapter 7: Regional analysis

Chapter 8: Market segmentation based on type applications

Chapter 9: Current and Future Trends

Request Customization as per your specific requirement@ https://www.emergenresearch.com/request-for-customization/1760

[globalgrowthinsights]

4K UST Projectors Market 2024: Emerging Trends, Major Driving Factors, Business Growth Opportunities

4K UST Projectors Market provides in-depth analysis of the market state of 4K UST Projectors manufacturers, including best facts and figures, overview, definition, SWOT analysis, expert opinions, and the most current global developments. The research also calculates market size, price, revenue, cost structure, gross margin, sales, and market share, as well as forecasts and growth rates. The report assists in determining the revenue earned by the selling of this report and technology across different application areas.

Geographically, this report is segmented into several key regions, with sales, revenue, market share and growth Rate of 4K UST Projectors in these regions till the forecast period

North America

Middle East and Africa

Asia-Pacific

South America

Europe

Key Attentions of 4K UST Projectors Market Report:

The report offers a comprehensive and broad perspective on the global 4K UST Projectors Market.

The market statistics represented in different 4K UST Projectors segments offers complete industry picture.

Market growth drivers, challenges affecting the development of 4K UST Projectors are analyzed in detail.

The report will help in the analysis of major competitive market scenario, market dynamics of 4K UST Projectors.

Major stakeholders, key companies 4K UST Projectors, investment feasibility and new market entrants study is offered.

Development scope of 4K UST Projectors in each market segment is covered in this report. The macro and micro-economic factors affecting the 4K UST Projectors Market

Advancement is elaborated in this report. The upstream and downstream components of 4K UST Projectors and a comprehensive value chain are explained.

Browse More Details On This Report at @https://www.globalgrowthinsights.com/market-reports/4k-ust-projectors-market-100577

 Global Growth Insights

Web: https://www.globalgrowthinsights.com

Our Other Reports:

Kids Retail Fitness MarketMarket Share

Passenger Boarding Bridge MarketMarket Growth Rate

Inhalation And Nasal Spray Generic Drugs MarketMarket Forecast

Global Medical Device Analytical Testing Outsourcing MarketMarket Size

Ultrasonic Level Sensors MarketMarket Growth

Vacuum Aluminum Plating Machine MarketMarket Analysis

Tricalcium Phosphate MarketMarket Size

Global Flow Cytometer Reagents MarketMarket Share

Global Camera Module MarketMarket Growth

Intranasal Drug Delivery Devices MarketMarket

Shared Mobility MarketMarket Share

Aminoethylethanolamine MarketMarket Growth Rate

Automotive CMOS Image Sensor MarketMarket Forecast

Global Biopesticides MarketMarket Size

Dermal Fillers and Botulinum Toxin MarketMarket Growth

Nitrile Butadiene Rubber (NBR) Powder MarketMarket Analysis

Automotive Vehicle To Everything (V2X) Communications MarketMarket Size

Global Hepatitis Drugs MarketMarket Share

Global Music Festival MarketMarket Growth

Mobile Payments MarketMarket

Iot Monetization MarketMarket Share

Digital Light Processing DLP Projector MarketMarket Growth Rate

Medical Device Contract Manufacturing MarketMarket Forecast

Global Semiconductor Packaging And Assembly Equipment MarketMarket Size

Home Meal Replacement Industry MarketMarket Growth

Grinding Media MarketMarket Analysis

Pad Printing Supplies MarketMarket Size

Global Sewing Thread MarketMarket Share

Global Ground Support Equipment (GSE) for OEM MarketMarket Growth

Surface-Enhanced Raman Spectroscopy (SERS) Substrate MarketMarket

Dog DNA Test MarketMarket Share

Carbonyl Iron Powder and Ultra Fine Iron Powder MarketMarket Growth Rate

Indocyanine Green MarketMarket Forecast

Global Toilet Bowls MarketMarket Size

Preimplantation Genetic Testing MarketMarket Growth

Dairy Packaging MarketMarket Analysis

Double-Sheet Control Sensor MarketMarket Size

Global LDI Exposure Machine MarketMarket Share

Global Ski Slope Material MarketMarket Growth

Polyolefin Plastomer (POP) MarketMarket

[creativeera]

Fill Finish Manufacturing Market is Estimated to Witness High Growth Owing to Increasing Demand

The fill finish manufacturing market involves various downstream processing methods in the production of pharmaceutical products and medical devices which includes pre-filling inspection and labeling. The fill finish processes encompass liquid filling as well as lyophilization, assembly, labeling and packaging of vials, syringes, and cartridges. It ensures optimal product quality, safety and integrity for final use. The fill finish manufacturing plays a crucial role in bringing biologics and vaccines to patients requiring strict adherence to regulations. The need for personalized medicine and shortage of vaccines during the COVID-19 pandemic has also propelled the demand in recent times. The fill finish manufacturing market is estimated to be valued at USD 16.41 Bn in 2024 and is expected to reach USD 30.36 Bn by 2031, exhibiting a compound annual growth rate (CAGR) of 9.2% from 2024 to 2031.

Key Takeaways Key players operating in the fill finish manufacturing market are Asymchem Inc., Syntegon Technology GmbH, I.M.A. INDUSTRIA MACCHINE AUTOMATICHE S.P.A, West Pharmaceutical Services, Inc., Gerresheimer AG, AptarGroup, Inc., Dätwyler Holding Inc., Stevanato Group, OPTIMA, SGD Pharma, Nipro Corporation, Bausch Advanced Technology Group, and Berry Global Inc. The key opportunities in the market include increased outsourcing activities by pharmaceutical companies and advanced technologies providing flexibility, connectivity and efficiency. Emerging economies in Asia Pacific and Latin America present lucrative growth prospects owing to rising healthcare expenditures and increasing biologics production. The Fill Finish Manufacturing Market Share is witnessing increased global expansion strategies by key market players through mergers, acquisitions and partnerships. This allows companies to broaden their service offerings and geographic footprints to tap high growth markets. Market drivers The major market driver is the rising demand for biologics and vaccines. Biologics have revolutionized the treatment of complex diseases but require specialized fill finish facilities owing to their sensitivity. Furthermore, inadequate vaccine supplies during the pandemic underscored the need to boost local manufacturing capacities through technology transfers. This is expected to drive greater outsourcing of fill finish activities to specialized contract service providers globally.

PEST Analysis Political: Regulations regarding pharmaceutical packaging have become increasingly stringent over the years, requiring compliance. This drives demand for technologically advanced fill and finish manufacturing solutions. Economic: With the economy recovering post-COVID and healthcare expenditure rising worldwide, the Fill Finish Manufacturing Market Challenges And Opportunities inindustry is benefitting from higher outsourcing and greater uptake of advanced machinery. Social: An aging global population is driving higher demand for medicines and therapeutics. Further, greater health awareness is boosting pharmacy visits and medication consumption. Technological: Advanced technologies like automation, Internet of Things connectivity, and digital manufacturing are being integrated to enhance production efficiency, throughput, quality control, and regulatory compliance documentation in fill and finish plants. Geographical regions of concentration The North American and European fill and finish manufacturing markets currently account for the largest share of the global market value, driven by strong domestic pharmaceutical industries and stringent quality and regulatory standards in countries like the US, Germany, France, and UK. Proximity to key pharmaceutical markets and customers provides an inherent advantage to manufacturers located in these regions. Fastest growing region The Asia Pacific region, led by China and India, is poised to witness the fastest growth in the fill and finish manufacturing market over the forecast period. This can be attributed to rising generic and biologics manufacturing in the region coupled with increasing localization requirements. Additionally, lower operating costs and a rapidly expanding local pharmaceutical customer base are encouraging global players to set up or expand operations in Asia Pacific.

PEST Analysis Political: Regulations regarding pharmaceutical packaging have become increasingly stringent over the years, requiring compliance. This drives demand for technologically advanced fill and finish manufacturing solutions. Economic: With the economy recovering post-COVID and healthcare expenditure rising worldwide, the fill and finish manufacturing industry is benefitting from higher outsourcing and greater uptake of advanced machinery. Social: An aging global population is driving higher demand for medicines and therapeutics. Further, greater health awareness is boosting pharmacy visits and medication consumption. Technological: Advanced technologies like automation, Internet of Things connectivity, and digital manufacturing are being integrated to enhance production efficiency, throughput, quality control, and regulatory compliance documentation in fill and finish plants. The North American and European fill and finish manufacturing markets currently account for the largest share of the global market value, driven by strong domestic pharmaceutical industries and stringent quality and regulatory standards in countries like the US, Germany, France, and UK. Proximity to key pharmaceutical markets and customers provides an inherent advantage to manufacturers located in these regions. The Asia Pacific region, led by China and India, is poised to witness the fastest growth in the fill and finish manufacturing market over the forecast period. This can be attributed to rising generic and biologics manufacturing in the region coupled with increasing localization requirements. Additionally, lower operating costs and a rapidly expanding local pharmaceutical customer base are encouraging global players to set up or expand operations in Asia Pacific.

Get more insights on Fill Finish Manufacturing Market

About Author:

Ravina Pandya, Content Writer, has a strong foothold in the market research industry. She specializes in writing well-researched articles from different industries, including food and beverages, information and technology, healthcare, chemical and materials, etc. (https://www.linkedin.com/in/ravina-pandya-1a3984191)

[ilmemcmi]

The Fututre of Contract Packaging Market Looks Bright Due to Growing Outsourcing Trends

The contract packaging market involves companies that package products on behalf of their clients. It allows brand owners to focus on core competencies while leveraging professional packagers’ expertise and infrastructure. The demand for outsourced packaging services is growing across industries like food & beverage, cosmetics, pharmaceuticals, and consumer goods. Manufacturers view contract packaging as a cost-effective strategy for small production runs, new product launches, and seasonal items. It provides flexibility to scale operations up or down quickly based on demand fluctuations.

The global contract packaging market was valued at US$ 60.5Bn in 2022, and is expected to exhibit a CAGR of 9.7%, in terms of revenue, over the forecast period (2023-2030) to reach US$ 127.1 Bn by 2030.

Rapid e-commerce growth and the need for warehouse automation are driving manufacturers to find packaging partners that can handle complex fulfillment tasks. Contract Packaging Market help brands improve supply chain responsiveness with just-in-time inventory management and reduced minimum order volumes. Their multi-client production models allow optimized facility utilization. Key Takeaways Key players in the contract packaging market include SUSI Studio, Insecta Shoes Canada Inc. ROMBAUT, In The Soulshine, Della La LLC, Reformation, Alabama Chanin, Wawwa, Doshi FCSA, Hiareth Collective, Komodo Fashion, Brave Gentle Man, ECOALF, Rapanui, and Tact & Stone. These companies have strong technical expertise across various packaging formats. They are making heavy investments in automated packaging lines and warehouse management systems. There are significant opportunities for contract packagers in the healthcare sector given the complexities of packaging temperature-controlled drugs and medical devices. They can assist pharmaceutical manufacturers achieve regulatory compliance while streamlining packaging operations. E-commerce growth is another key opportunity as online retailers require flexible multi-channel fulfillment from packaging partners. Globally, countries like China, India, and Mexico are attractive destinations for contract packagers looking to expand. Their lower costs and growing consumer markets are encouraging Western brands to switch to Asian contract manufacturers. At the same time, many Asian packagers are setting up facilities in the US and Europe to better serve local and export clients. Market Drivers One key driver for the contract packaging market is the trend of outsourcing non-core activities. Manufacturers want to focus on R&D, branding and sales while leveraging the expertise of specialist packagers. This helps optimize capital and reduces fixed costs. Market Restraints Over-reliance on a single contract packager can be risky if there are issues with quality, capacity or delivery timelines. Setting up multiple packaging partners requires higher coordination costs. There is also a lack of standardization in regulatory guidelines for packaging certain products like medicines across countries. This poses compliance challenges.

Segment Analysis For contract packaging market, the dominating sub segment is flexible packaging which holds around 60% market share. Flexible packaging provides convenience of re-sealability and easy handling to end users. Products such as baked foods, snacks, confectionery items are mostly shipped in flexible pouches or bags. Emerging e-commerce sector further propels the demand for flexible packages as such packages protects the product from external damage during shipping and distribution. Another major sub segment is rigid plastic packaging which holds around 25% share. Rigid plastic packaging involves use of materials such as plastics, glass for rigid containers. Products from industries like food, beverage, pharmaceutical among others widely use rigid plastic packs for sturdiness during transportation. Rising demand for packaged consumables drives the need for rigid plastic containers in contract packaging market. Global Analysis The Asia Pacific region holds the largest share in global contract packaging market currently. Growing middle class population, changing lifestyles and urbanization in countries like China and India augments the demand for packaged food and beverage items. This drives the contract packaging needs in Asia Pacific region. North America follows Asia Pacific in terms of market share. Rapid uptake of online shopping and increasing preference for small pack sizes supplements the contract packaging sector growth in North America. Europe, Latin America and Middle East & Africa also create profitable opportunities for contract packaging market players owing to expanding manufacturing industries and consumer base in these regions.

Gets More Insights on, Contract Packaging Market

About Author:

Ravina Pandya, Content Writer, has a strong foothold in the market research industry. She specializes in writing well-researched articles from different industries, including food and beverages, information and technology, healthcare, chemical and materials, etc. (https://www.linkedin.com/in/ravina-pandya-1a3984191)

[healthcaremarketanalysis]

Global Prefilled Syringes Market worth $8.6 billion by 2025

The size of global prefilled syringes market in terms of revenue was estimated to be worth $5.6 billion in 2020 and is poised to reach $8.6 billion by 2025, growing at a CAGR of 9.0% from 2020 to 2025. The research study consists of industry trends, pricing analysis, patent analysis, conference and webinar materials, key stakeholders, and buying behaviour in the market.

Download PDF Brochure:

Increasing adoption of self-administered injectable drugs is expected to result in the segment occupying the majority of the industry share

The conventional Prefilled Syringes Market is estimated to have the largest market share by value. Growth of this segment can be attributed to the the advantages offered, such as safe administration, ease of use for both healthcare professionals and end users, reduced risk of contamination of the product, less waste of costly API, ease of manufacturing, improved dosing accuracy, and enhanced product differentiation when compared to vials is expected to drive the market growth.

By type, the safety prefilled syringes segment of prefilled syringes industry, is expected to grow at the highest CAGR during the forecast period

The safety prefilled syringes segment is expected to witness the highest growth during the forecast period primarily due to the rising geriatric population globally and availability of biological therapies for patients with chronic conditions and outsourcing of low-risk medical procedures for chronic patients alleviates some of the pressure on hospitals

Glass prefilled syringes is the largest material segment of the prefilled syringes industry

The glass prefilled syringes segment accounted for the largest share of the global industry in 2019. The large share of this segment is attributed to the significant benefits offered, such as prevention of oxygen and water vapor from interacting with drug compounds, compatibility with different filling machines, and seamless integration into pharmaceutical companies’ PFS operations.

Single-chamber prefilled syringes accounted for the largest share of the prefilled syringes industry, by design

The single-chamber prefilled syringes segment accounted for the largest share of the global industry in 2019. Market growth can largely be attributed to the significant advantages with the use of single-chamber prefilled syringes over vials, such as optimized API use with less overfill, reduced material requirements, less drug waste in clinical trials, and simple storage & disposal. Additionally, increasing adoption of self-administered parenteral drugs due to the increasing prevalence of chronic diseases and benefits offered by prefilled syringes.

Europe is the largest regional market for prefilled syringes

Europe is one of the major revenue-generating regions in the global market. Rising prevalence of chronic diseases, growth of the biologics and biosimilars market, technological advancements, geographical expansion by key manufacturers, aging population, and high adoption of self-injection devices are driving the demand for self-injectable prefilled syringes.  are the major factors driving the growth of the global market in Europe.

Global players operating in the global prefilled syringes market are Becton, Dickinson and Company (US), Gerresheimer (Germany), SCHOTT AG (Germany), West Pharmaceutical Services, Inc. (US), Baxter International Inc (US), Ompi (Italy), Catalent, Inc. (US), Weigao Group (China), Vetter Pharma International GmbH (Germany), Nipro Corporation (Japan), Elcam Medical (Israel), YPSOMED (Switzerland), Oval Medical Technologies (UK), SHL Medical AG (Switzerland), Terumo (Japan).

Recent Developments

In October 2018, Becton, Dickinson and Company launched the BD Intevi 1mL two-step disposable autoinjector.

In July 2020, Becton, Dickinson and Company entered into an partnership with Biomedical Advanced Research and Development Authority (BARDA) (US)

In July 2018, Becton, Dickinson and Company acquired Teva Medical Inc. (US)

[health-views-updates]

The Future of the Healthcare Contract Research Organization Market: Insights and Projections

Healthcare Contract Research Organization Market Outlook, Scope & Overview:

Industry reports indicate that the global healthcare contract research organization (CRO) market was valued at USD 50.5 billion in 2023 and is projected to reach USD 88.07 billion by 2031, growing at a CAGR of 7.2% over the forecast period 2024-2031.

Technological Advancements to Drive Growth of Global Healthcare CRO Market

The adoption of healthcare contract research organizations will continue to influence global market revenues. Pharmaceutical, biotechnology, and medical device companies are increasingly outsourcing clinical trials and research activities to CROs to accelerate drug development, reduce costs, and leverage specialized expertise.

As a service segment, clinical trial services currently hold a significant share of the global healthcare CRO market. This segment is anticipated to grow at a year-over-year rate of 7.2% in 2024 over 2023 and reach USD 88.07 billion in revenues by 2031. The increasing complexity of clinical trials, the rising number of biopharmaceutical companies outsourcing R&D activities, and the growing demand for innovative therapies are expected to drive market growth.

Healthcare Contract Research Organization Services – Market Dynamics

Drivers:

Healthcare CRO services are witnessing significant growth in the global market due to their ability to provide expertise in clinical trial design, patient recruitment, data management, and regulatory compliance. The increasing focus on personalized medicine, the rising prevalence of chronic diseases, and the need for faster market approvals are key factors driving the adoption of CRO services worldwide. Additionally, advancements in technology, such as artificial intelligence and big data analytics, are enhancing the efficiency and accuracy of clinical trial processes, further propelling market growth.

Restraints:

Despite the growth potential, challenges such as regulatory uncertainties, fluctuations in R&D budgets of pharmaceutical companies, and the risk of data breaches are hindering the widespread adoption of healthcare CRO services. Moreover, the need for stringent quality standards, the complexity of managing global clinical trials, and the shortage of skilled professionals in certain regions pose additional challenges to market expansion.

Healthcare Contract Research Organization Services – Market Outlook

The proven benefits of healthcare CRO services in accelerating drug development timelines, reducing operational costs, and mitigating R&D risks have contributed to the market's growth. CRO services are expected to witness increased adoption across major healthcare markets, including North America, Europe, and Asia Pacific, driven by advancements in clinical research methodologies and the increasing globalization of drug development activities.

Global Healthcare Contract Research Organization Market

The rise in demand for healthcare CRO services in developed and emerging markets is expected to drive market growth over the forecast period. North America currently holds a significant market share in the global healthcare CRO market, with the US being a key contributor to market revenues. Europe and Asia Pacific regions are also experiencing rapid growth in CRO services, supported by favorable regulatory environments and increasing investments in biomedical research.

Key Players in the Healthcare Contract Research Organization Market

Leading companies in the healthcare CRO market include IQVIA, Laboratory Corporation of America Holdings (LabCorp), PPD, Inc., and ICON plc. These companies specialize in providing a wide range of clinical trial and research services, including drug development, clinical data management, and regulatory affairs.

In conclusion, the global healthcare contract research organization market is poised for steady growth over the forecast period, driven by increasing R&D outsourcing by pharmaceutical companies, advancements in clinical trial technologies, and the growing complexity of drug development processes.

Other Trending Reports

Portable Ultrasound Market Share by Company

mRNA Therapeutics Market Share by Company

Remote Patient Monitoring (RPM) Market Share by Company

Dental Imaging Market Share by Company

[wellnessweb]

Trends Influencing the Growth of the Healthcare CRO Market Size

The Healthcare Contract Research Organization Market Size was valued at USD 50.5 billion in 2023 and is expected to reach USD 88.07 billion by 2031, and grow at a CAGR of 7.2% over the forecast period 2024-2031.The Healthcare Contract Research Organization (CRO) market is a dynamic ecosystem vital to advancing medical research and development globally. As pharmaceutical and biotechnology companies increasingly outsource clinical trials and research activities, CROs play a pivotal role in ensuring efficiency, compliance, and scientific rigor. These organizations provide specialized services ranging from clinical trial management and regulatory affairs to data management and biostatistics. In an era marked by rapid advancements in medical technology and therapies, CROs serve as invaluable partners, navigating complex regulatory landscapes and accelerating the journey from laboratory discovery to patient treatment.

Get Sample Of This Report @ https://www.snsinsider.com/sample-request/1523

Market Scope & Overview

The market research report is a complete and in-depth analysis of the major regional market conditions around the world, with a focus on the most significant countries and regions. The SWOT analysis of a new project, the viability of an investment, and an analysis of the investment return were all included in the Healthcare Contract Research Organization Market  research. After discussing product specifications, production procedures, cost structures, and raw materials, definitions, classifications, applications, and market overviews were covered.

Industry forecasts, top global competitors and suppliers, regional market share, market state and development trends by types and applications, pricing and profit status, marketing situation, market growth factors and challenges, new company and product introductions, and other topics are all covered. The market conditions for keywords are then assessed throughout the major geographic regions of the world, taking into account a number of variables.

Market Segmentation Analysis

By Service Type

Early Phase Development

Laboratory Services

Clinical development services

Consulting Services

By Therapeutic Type

Oncology

CNS Disorder

Infectious Disease

Cardiovascular Disease

Metabolic Disease

Diabetes

Others

By End User

Pharmaceutical companies

Medical Device Companies

Academic Institutes

COVID-19 Impact Analysis

The qualitative market analysis in the Healthcare Contract Research Organization Market  research report examines factors such as market entrance strategy analysis, COVID-19 industry trends, PEST analysis, market growth drivers and inhibitors, and more.

Regional Analysis

The key geographical areas of the world, including North America, Latin America, Europe, Asia Pacific, and the Middle East and Africa, are thoroughly covered in the Healthcare Contract Research Organization Market  research report. The report also covers significant investments, existing opportunities, and recent changes in these regions.

Competitive Outlook

The main market players included in the research are participants, raw material suppliers, equipment suppliers, end users, traders, distributors, and others. This research report also includes detailed corporation biographies. Capacity, production, revenue, cost, gross margin, sales revenue, consumption, growth rate, supply, future plans, and technical improvements are a few of the variables to take into account. The research study offers a thorough analysis of the Healthcare Contract Research Organization Market , including data on a variety of market players, the competitive environment, anticipated future growth, and important risks.

Key Reasons to Buy Healthcare Contract Research Organization Market  Report

Gain a thorough awareness of the global market and its commercial environment through thorough market research.

Recognize the most important business motivating and inhibiting factors and their effects on the world market.

Conclusion

The market research report's goal is to examine the situation of the Healthcare Contract Research Organization Market  now and possible sources of income. It looks at all aspects of the market ecology, including developments in technology, applications and end users, product offers, the legal and regulatory landscape, and market expansion strategies.

About US

SNS Insider is a market research and insights firm that has won several awards and earned a solid reputation for service and strategy. We are a strategic partner who can assist you in reframing issues and generating answers to the trickiest business difficulties. For greater consumer insight and client experiences, we leverage the power of experience and people.

When you employ our services, you will collaborate with qualified and experienced staff. We believe it is crucial to collaborate with our clients to ensure that each project is customized to meet their demands. Nobody knows your customers or community better than you do. Therefore, our team needs to ask the correct questions that appeal to your audience in order to collect the best information.

Related  Reports

Nucleotide Market Trends

Nutrigenomics Market Trends

Oncology Drugs Market Trends

Opioid Use Disorder Market Trends

Orthobiologics Market Trends

[industrynewsupdates]

Pharmaceutical Analytical Testing Outsourcing Market 2024-2030: Trends and Opportunities

The global pharmaceutical analytical testing outsourcing market size was valued at USD 8.3 billion in 2023 and is projected to grow at a CAGR of 8.4% from 2024 to 2030.

Growth in the market can be attributed due to increasing focus toward safety, & quality; regulation, pricing benefits of outsourcing, and rising number of end use. Besides, increasing R&D investment is one of the critical sustainability strategies adopted by market players. As, not all companies have an infrastructure for analytical testing. Therefore, outsourcing these operations is a suitable option, which helps to save time and cost.

Gather more insights about the market drivers, restrains and growth of the Pharmaceutical Analytical Testing Outsourcing Market 

Other factors, such as the changing regulations for in vivo and in vitro tests, are also expected to propel the growth of the market for pharmaceutical analytical testing outsourcing. Besides, high demand for quality generic drugs, analytical testing methods, improved the quality and transparency of the review & approval process, and encourage new drug R&D in line with global development is anticipated to fuel the market growth.

In addition, innovation or new product development is directly proportional to the demand for testing services due to pricing concerns, competitive pressures, and lead-time to market, companies are opting for outsourcing of testing services. Moreover, focus on customized care and technological advancements, which has resulted in rapid development of new products. Likewise, development of biosimilar, combination products, and other innovative medicines has fueled the demand for pharmaceutical analytical testing services.  

Browse through Grand View Research's Medical Devices Industry Research Reports.

• The global pharmaceutical regulatory affairs market size was estimated at USD 8.84 billion in 2023 and is projected to grow at a CAGR of 7.16% from 2024 to 2030. 

• The global pharmaceutical packaging market size was valued at USD 139.37 billion in 2023 and is expected to grow a compound annual growth rate (CAGR) of 9.7% from 2024 to 2030.

Pharmaceutical Analytical Testing Outsourcing Market Segmentation

Grand View Research has segmented the prebiotic ingredient market based on type, application, and region:

Type Outlook (Revenue, USD Million, 2017 - 2028)

• Inulin

• Oligosaccharide (MOS/GOS/FOS)

• Others

Applications Outlook (Revenue, USD Million, 2017 - 2028)

• Food & Beverage

• Dietary Supplements

• Others

Regional Outlook (Revenue, USD Million, 2017 - 2028)

• North America

• Europe

• Asia Pacific

• Central & South America

• Middle East & Africa

Key Companies & Market Share Insights

Companies' are focusing on innovating new types of prebiotic ingredients to meet the increasing demand. New players are entering the market owing to low market entry barriers and higher market potential. The increasing demand for prebiotic ingredients offers an opportunity for product development in the regions of high demand. Some of the prominent players in the global prebiotic ingredient market include:

• Beneo-Orafti SA

• Tereos Group

• Ingredion Inc.

• Cargill Inc.

• DowDuPont Inc

• Royal FrieslandCampina N.V.

• Kerry Group

• Cosucra-groupe Warcoing SA

• Sensus BV

Recent Developments

• In December 2023, Agno Pharma acquired Lubrizol Particle Sciences Inc. The acquisition encompasses the drug product formulation technology integral to Particle Sciences Inc. including the PA, Bethlehem development & manufacturing site.

• In November 2023, Eurofins acquired Quasfar supporting the pharmaceutical industry in Latin America, enhancing its capabilities in R&D, providing support in the early stages of pharmaceutical product development.

Order a free sample PDF of the Pharmaceutical Analytical Testing Outsourcing Market Intelligence Study, published by Grand View Research. 

[boatarenttahoe]

Early Phase Clinical Trial Outsourcings Market Scope & Growth Projection till 2032

Early Phase Clinical Trial Outsourcings Market provides in-depth analysis of the market state of Early Phase Clinical Trial Outsourcings manufacturers, including best facts and figures, overview, definition, SWOT analysis, expert opinions, and the most current global developments. The research also calculates market size, price, revenue, cost structure, gross margin, sales, and market share, as well as forecasts and growth rates. The report assists in determining the revenue earned by the selling of this report and technology across different application areas.

Geographically, this report is segmented into several key regions, with sales, revenue, market share and growth Rate of Early Phase Clinical Trial Outsourcings in these regions till the forecast period

North America

Middle East and Africa

Asia-Pacific

South America

Europe

Key Attentions of Early Phase Clinical Trial Outsourcings Market Report:

The report offers a comprehensive and broad perspective on the global Early Phase Clinical Trial Outsourcings Market.

The market statistics represented in different Early Phase Clinical Trial Outsourcings segments offers complete industry picture.

Market growth drivers, challenges affecting the development of Early Phase Clinical Trial Outsourcings are analyzed in detail.

The report will help in the analysis of major competitive market scenario, market dynamics of Early Phase Clinical Trial Outsourcings.

Major stakeholders, key companies Early Phase Clinical Trial Outsourcings, investment feasibility and new market entrants study is offered.

Development scope of Early Phase Clinical Trial Outsourcings in each market segment is covered in this report. The macro and micro-economic factors affecting the Early Phase Clinical Trial Outsourcings Market

Advancement is elaborated in this report. The upstream and downstream components of Early Phase Clinical Trial Outsourcings and a comprehensive value chain are explained.

Browse More Details On This Report at @https://www.globalgrowthinsights.com/market-reports/early-phase-clinical-trial-outsourcings-market-101449

 Global Growth Insights

Web: https://www.globalgrowthinsights.com

Our Other Reports:

Global Early Phase Clinical Trial Outsourcings Market Share

Smart Microwave Oven Market Forecast

Shot Peening Market Size

Spectrometer Market Growth Rate

Operating Room Management Market Analysis

Indoor Location-based Services (LBS) Market Share

Digital Refractometers Market Growth

Electric Trucks Market

Global CMP Pad Regulator Market Size

Global Advanced Metering Infrastructure (AMI) Market Growth

RFID Printer Market Forecast

Global Laser Communication Terminal Market Share

Concrete Waterproofing Admixture Market Growth Rate

Thermal Treatment Air Filtration Systems Market Size

5G Security Market Share

Single Lead ECG Equipment Market Analysis

Personal Cloud Market

Fiber Coupled Superluminescent Light Emitting Diodes (SLED) Market Growth

Global Digital Talent Acquisition Market Growth

Global Hydraulic Dock Leveler Market Size

Global Robotic Process Automation Market Share

Carpet Manufacturing Machines Market Forecast

EV Charging Cables Market Size

Lighters Market Growth Rate

Reduced Iron Powder Market Analysis

Medical Audiometers Market Share

Peptide CDMO Market Growth

Intelligent Flow Meter Market

Global Tax Management Software Market Size

Global Aqua Feed Market Growth

Refurbished Medical Devices Market Forecast

Global Civil Engineering Design Software Market Share

Invisible Orthodontics Market Growth Rate

Self-Tanning Products Market Size

Laser Communications Terminals (LCTs) Market Share

Flower Pots and Planters Market Analysis

Battery Energy Storage Systems (BESS) Market

Potassium Bicarbonate Market Growth

Optical Transceivers Market Size

Digital Twin Technology Market Share

[tamanna31]

Biopharmaceuticals Contract Manufacturing Market Poised for Steady Growth in the Future

Biopharmaceuticals Contract Manufacturing Industry Overview

The global biopharmaceuticals contract manufacturing market was valued at USD 17.0 billion in 2021 and is projected to grow at a compound annual growth rate (CAGR) of 5.2% during the forecast period.

The success of the biopharmaceutical market can be majorly attributed to the contract manufacturers. Reduction in the overall investment required to bring a new drug product to market, providing access to expensive technologies, quick entry of products into the markets, and greater flexibility are some advantages offered by contract manufacturing organizations (CMOs), which have prompted the companies to outsource their biopharmaceutical manufacturing.

Due to the disruptions from COVID-19, many companies have had to bring on new contract manufacturers or ingredient suppliers due to increasing demands. Furthermore, with a perpetual expansion of the biopharmaceutical industry, the companies are facing production issues, such as lack of expertise and sophisticated equipment, while practicing in-house manufacturing. The maturity of biotechnology and the availability of external funding have resulted in the growth in a number of early-stage bio/pharma companies. These companies are recognized as core customers of CMOs, as these organizations lack the capabilities for the development of robust manufacturing operations.

Gather more insights about the market drivers, restrains and growth of the Biopharmaceuticals Contract Manufacturing Market

In order to fulfill the growing demand in the market, key players are going for capacity expansion. For instance, in 2020, Thermo Fisher Scientific announced an investment of USD 180.0 million for the construction of a new commercial manufacturing site in Plainville, Mass for viral vector development and manufacturing services. Also, in 2019, Boehringer Ingelheim invested USD 84 million for expansion in Mexico for increasing production. The customers and CMOs are engaged in standardizing agreement terms for making contract negotiations easy. This is to address the issues pertaining to the regulatory landscape and complexity of service delivery. IP rights, warranty & liabilities, prices & timelines are major issues cited by CMOs and clients which are making negotiations innately difficult.

Breakthrough technological advancements and innovations in bioprocessing have played a pivotal role in the progress of contract service providers by overcoming the manufacturing issues such as high production costs and the need for changeover with every batch. Single-use bioprocessing systems are one of the most significant innovations as it helps in reducing the overall production and scale-up costs. Furthermore, the fast turnaround offered by single-use products while limiting allied activities, such as changeover and cleaning validation, has supported the growth of CMOs to a major extent.

Mergers, acquisitions, and joint ventures are one of the common trends observed across the industry, as it helps CMOs offer integrated bioprocessing services to their clients, which, in turn, makes them a more reliable option for a rapid product launch for commercial use. However, large firms consider outsourcing perilous due to loss of strategic control and limited management oversight. As a result, large pharma companies opt to maintain their manufacturing operations in-house. This is expected to challenge the growth of CMOs to a certain extent.

Browse through Grand View Research's Medical Devices Industry Research Reports.

• The global intrauterine devices market size was estimated at USD 6.25 billion in 2023 and is projected to grow at a CAGR of 3.66% from 2024 to 2030.

• The global dual chamber prefilled syringes market size was valued at USD 167.3 million in 2023 and is projected to grow at a CAGR of 5.8% from 2024 to 2030.

Key Companies and Market Share Insights

The market service providers are focused on expanding their manufacturing capabilities as well as establishing new services to meet the growing demand of biopharmaceutical companies. Along with small players, these entities are also engaged in a partnership with established biopharma companies.

All the major biopharmaceutical firms have a wide-ranging product pipeline and are investing in developing new products. For instance, more than 60,000 clinical trials were registered globally in 2018. It is challenging for biopharmaceutical players to carry out regulatory-compliant manufacturing processes solely depending on in-house capacities. This, in turn, is driving the demand for biopharmaceutical contract manufacturing of potential drug candidates all across the globe. Some prominent key players in the global biopharmaceuticals contract manufacturing market include:

·         Boehringer Ingelheim GmbH

·         Lonza

·         Inno Biologics Sdn Bhd

·         Rentschler Biotechnologie GmbH

·         JRS PHARMA

·         AGC Biologics

·         ProBioGen

·         FUJIFILM Diosynth Biotechnologies U.S.A., Inc.

·         Toyobo Co. Ltd.

·         Samsung BioLogics

·         Thermo Fisher Scientific, Inc.

·         Binex Co., Ltd.

·         WuXi Biologics

·         AbbVie, Inc.

·         Novartis AG

·         ADMA Biologics, Inc.

·         Catalent, Inc

·         Cambrex Corporation

·         Pfizer Inc.

·         Siegfried Holding AG

Order a free sample PDF of the Biopharmaceuticals Contract Manufacturing Market Intelligence Study, published by Grand View Research.

[tmr-blogs2]

Powder Metallurgy Market Size & Share to Hit USD 14.4 billion by 2031, Garnering a 7.7% CAGR from 2021 to 2031

The global powder metallurgy market was estimated to have acquired US$ 6.4 billion in 2020. It is anticipated to register a 7.7% CAGR from 2021 to 2031 and by 2031, the market is likely to gain US$ 14.4 billion.

One unique opportunity in the powder metallurgy market is the growing demand for advanced powder metallurgy techniques in the development of additive manufacturing (3D printing) materials. Powder metallurgy offers the ability to create intricate and highly customized metal components, making it well-suited for 3D printing applications in various industries, including aerospace, healthcare, and automotive.

This emerging trend provides a niche for powder metallurgy to play a vital role in producing high-performance, complex, and lightweight parts, opening up new avenues for innovation and market growth.

Download PDF Brochure: https://www.transparencymarketresearch.com/sample/sample.php?flag=S&rep_id=3468  

Market Segmentation

The powder metallurgy market can be segmented based on service type, sourcing type, application, industry vertical, and region.

By Service Type

Production Services: Including compacting, sintering, and post-processing services.

Material Services: Involving the supply of metal powders and additives.

By Sourcing Type

In-house Manufacturing: Companies with in-house PM capabilities.

Contract Manufacturing: Outsourcing PM processes to specialized manufacturers.

By Application

Automotive: Components like gears, bearings, and filters.

Aerospace: Lightweight structural components and engine parts.

Medical: Orthopedic implants and dental devices.

Electronics: Magnetic materials and conductive components.

By Industry Vertical

Automotive

Aerospace

Medical

Electronics

Industrial Machinery

By Region

North America

Europe

Asia-Pacific

Latin America

Middle East & Africa

Regional Analysis

North America

North America is a leading market for powder metallurgy, driven by significant demand in the automotive and aerospace sectors. The presence of major manufacturers and ongoing research and development initiatives further bolster the market in this region.

Europe

Europe holds a substantial share in the powder metallurgy market, with Germany, France, and the UK being key contributors. The region's focus on sustainable manufacturing practices and advancements in PM technology are driving growth.

Asia-Pacific

The Asia-Pacific region is expected to witness the highest growth rate, supported by rapid industrialization, especially in China, Japan, and India. The automotive and electronics industries are major drivers of PM market expansion in this region.

Latin America and Middle East & Africa

These regions are gradually increasing their adoption of powder metallurgy, with growing investments in the automotive and aerospace sectors. However, the market share remains relatively smaller compared to North America, Europe, and Asia-Pacific.

Market Drivers and Challenges

Drivers

Technological Advancements: Innovations in PM processes and materials are enhancing efficiency and expanding application areas.

Environmental Benefits: Reduced material waste and energy consumption make PM a preferred choice for sustainable manufacturing.

Increasing Demand in Key Industries: The automotive, aerospace, and medical industries are major consumers of PM components, driving market growth.

Challenges

High Initial Costs: The setup costs for PM manufacturing can be substantial, posing a barrier for new entrants.

Technical Limitations: Some limitations in material properties and the complexity of certain shapes may restrict the adoption of PM.

Market Trends

Additive Manufacturing Integration: The combination of PM with additive manufacturing techniques is creating new opportunities for complex and customized components.

Sustainable Practices: There is a growing emphasis on environmentally friendly manufacturing processes, driving the adoption of PM.

Material Innovations: Development of new metal powders and composites is expanding the capabilities and applications of PM.

Future Outlook

The future of the powder metallurgy market looks promising, with continuous advancements in technology and materials expected to overcome current limitations. The increasing demand for lightweight, high-strength components in automotive and aerospace sectors will further propel market growth.

Key Market Study Points

The market is set to grow at a CAGR of 4.5% from 2021 to 2031.

Automotive and aerospace industries are the primary drivers of demand.

Technological advancements and sustainable practices are key trends.

North America and Asia-Pacific are the leading regions in market growth.

Competitive Landscape

The powder metallurgy market is highly competitive, with key players including GKN Powder Metallurgy, Höganäs AB, Sumitomo Electric Industries, and Sandvik AB. These companies are focusing on strategic partnerships, acquisitions, and innovations to maintain their market position.

Place an Order Copy of Powder Metallurgy Market Report at: https://www.transparencymarketresearch.com/checkout.php?rep_id=3468&ltype=S

Recent Developments

GKN Powder Metallurgy: Recent investments in expanding production capacity and enhancing material capabilities.

Höganäs AB: Development of new metal powders tailored for additive manufacturing applications.

Sumitomo Electric Industries: Introduction of advanced sintering technologies to improve component performance.

About Transparency Market Research

Transparency Market Research, a global market research company registered at Wilmington, Delaware, United States, provides custom research and consulting services. Our exclusive blend of quantitative forecasting and trends analysis provides forward-looking insights for thousands of decision makers. Our experienced team of Analysts, Researchers, and Consultants use proprietary data sources and various tools & techniques to gather and analyses information.

Our data repository is continuously updated and revised by a team of research experts, so that it always reflects the latest trends and information. With a broad research and analysis capability, Transparency Market Research employs rigorous primary and secondary research techniques in developing distinctive data sets and research material for business reports.

Contact:

Transparency Market Research Inc.

CORPORATE HEADQUARTER DOWNTOWN,

1000 N. West Street,

Suite 1200, Wilmington, Delaware 19801 USA

Tel: +1-518-618-1030

USA – Canada Toll Free: 866-552-3453

Website: https://www.transparencymarketresearch.com